Health News

A new way to target high rates of obesity

A novel drug is being touted as a major step forward in the battle against Australia’s escalating rates of obesity and associated metabolic diseases. As it stands, 2 in 3 adults in Australia are classified as being overweight or obese. A long-term study between researchers at the Centenary Institute and UNSW Sydney has led to […]

Kids Health

Getting kids ready for the new school year

(HealthDay)—There are a number of things you can do to ensure your kids have a smooth start to the new school year. Don’t wait until the first day of class to seek help. Schools are open over the summer to address any concerns you or your child might have, and the best time to get […]

Health Problems

New assay to detect genetic abnormalities in sarcomas outperforms conventional techniques

Sarcomas are rare tumors that are often misdiagnosed. Specific recurrent chromosomal rearrangements, known as translocations, can serve as essential diagnostic markers and are found in about 20 percent of sarcomas. Identification of these translocations helps establish a correct diagnosis and guides treatment. A report in the Journal of Molecular Diagnostics describes a new assay, anchored […]

Personal Health

New algorithm could improve diagnosis of rare diseases

Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up. In a paper published July 12 in Genetics in Medicine, Bejerano and his colleagues describe an algorithm they’ve developed that automates the most […]

Health News

New Drug of Last Resort Tackles Resistant HIV

THURSDAY, Aug. 16, 2018 — HIV, the virus that causes AIDS, is typically a manageable infection, but medications that keep the virus at bay don’t work for everyone. Now, researchers have developed a new medication to help them. The U.S. Food and Drug Administration approved the drug — ibalizumab (Trogarzo) — in March. Phase 3 […]